» Articles » PMID: 4375525

The Nature of the Binding Between LSD and a 5-HT Receptor: a Possible Explanation for Hallucinogenic Activity

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1974 Jun 1
PMID 4375525
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

1 (+)-Lysergic acid diethylamide (LSD) mimicked 5-hydroxytryptamine (5-HT) in its ability to stimulate fluid secretion, to change transepithelial and intracellular potentials as well as to increase the cyclic 3',5'-adenosine monophosphate (cyclic AMP) concentrations of isolated salivary glands of Calliphora.2 Unlike 5-HT, LSD disengages slowly from the receptor and fluid secretion continues despite repeated washing.3 Both 5-HT and tryptamine prevented LSD from acting on the glands.4 LSD bound to the receptor was slowly displaced when glands were treated with agonists (tryptamine) or antagonists (gramine).5 The property of LSD which permits it to function as an agonist despite remaining tightly bound to the receptor is discussed as a possible basis for its profound effects within the central nervous system.

Citing Articles

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.

Barker S Front Neurosci. 2018; 12:536.

PMID: 30127713 PMC: 6088236. DOI: 10.3389/fnins.2018.00536.


Unique pharmacological properties of serotoninergic G-protein coupled receptors from cestodes.

Camicia F, Celentano A, Johns M, Chan J, Maldonado L, Vaca H PLoS Negl Trop Dis. 2018; 12(2):e0006267.

PMID: 29425245 PMC: 5823469. DOI: 10.1371/journal.pntd.0006267.


Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.

Schindler E, Harvey J, Aloyo V Brain Res. 2012; 1491:98-108.

PMID: 23123701 PMC: 3559188. DOI: 10.1016/j.brainres.2012.10.057.


Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).

Schindler E, Dave K, Smolock E, Aloyo V, Harvey J Pharmacol Biochem Behav. 2011; 101(1):69-76.

PMID: 22197710 PMC: 3272148. DOI: 10.1016/j.pbb.2011.12.002.


Vasopressin-like effects of psychotropic drugs in amphibian epithelia.

Grosso A, de Sousa R J Membr Biol. 1978; 40 Spec No:305-21.

PMID: 104041 DOI: 10.1007/BF02026013.

References
1.
Berridge M, Prince W . Transepithelial potential changes during stimulation of isolated salivary glands with 5-hydroxytryptamine and cyclic AMP. J Exp Biol. 1972; 56(1):139-53. DOI: 10.1242/jeb.56.1.139. View

2.
Gaddum J . Serotonin-LSD interactions. Ann N Y Acad Sci. 1957; 66(3):643-7; discussion, 647-8. DOI: 10.1111/j.1749-6632.1957.tb40754.x. View

3.
Boakes R, Bradley P, Briggs I, Dray A . Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25. Br J Pharmacol. 1970; 40(2):202-18. PMC: 1702892. DOI: 10.1111/j.1476-5381.1970.tb09914.x. View

4.
WOOLLEY D, Shaw E . Evidence for the participation of serotonin in mental processes. Ann N Y Acad Sci. 1957; 66(3):649-65; discussion, 665-7. DOI: 10.1111/j.1749-6632.1957.tb40755.x. View

5.
Baker R, Chothia C, Pauling P, Weber H . Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine. Mol Pharmacol. 1973; 9(1):23-32. View